CELL AND GENE THERAPY INSIGHTS

Filter by Interests

Filter by ContentType

Accelerating digitization in cell & gene therapy manufacturing: real-world insights & practical strategies

Accelerating digitization in cell & gene therapy manufacturing: real-world insights & practical strategies

R Street-Howard, T Ala, C Baldwin et al
10 December 2025
Register
 Automating and scaling adherent cell manufacturing for clinical and commercial success

Automating and scaling adherent cell manufacturing for clinical and commercial success

Nathan Frank, Mandana Haack-Sørensen
04 December 2025
Register
 Key considerations for selecting raw materials in gene therapy manufacturing: expertise, scalability and compliance

Key considerations for selecting raw materials in gene therapy manufacturing: expertise, scalability and compliance

Amelie Bauer, Ulrike Strauss, Nicholas DePrimo
02 December 2025
Register
 Unlock advanced strategies in cell therapy analytics

Unlock advanced strategies in cell therapy analytics

S Krause, K Shum, A Chandran et al
25 November 2025
Register
 Process optimization and digital integration strategies to scale cell and gene therapy

Process optimization and digital integration strategies to scale cell and gene therapy

 Negre, N Glaserman , M Djemai et al
19 November 2025
Register
 Scaling AAV5 production from bench to industrial scale: strategies for efficient, de-risked manufacturing

Scaling AAV5 production from bench to industrial scale: strategies for efficient, de-risked manufacturing

Anne MacIntyre, Sara Krekels
18 November 2025
Register
 Smarter lentiviral manufacturing for CAR-T: increased productivity meets smart purification

Smarter lentiviral manufacturing for CAR-T: increased productivity meets smart purification

Jean-Simon Diallo, Jason Slingby
12 November 2025
Register
 Advancing CAR-T cell manufacturing with modular design and robotics

Advancing CAR-T cell manufacturing with modular design and robotics

Alaina Schlinker, Ph.D., Edwin Stone, Ph.D., Melissa DeFrancesco, Ph.D.
11 November 2025
Register
 Tailoring viral clearance study design to development phase, modality, and regulatory requirements

Tailoring viral clearance study design to development phase, modality, and regulatory requirements

Kathleen Kenney
05 November 2025
Register
 Collection to commercialization: is standardization the bottleneck or breakthrough for cell and gene therapy

Collection to commercialization: is standardization the bottleneck or breakthrough for cell and gene therapy

D Fink, K Carlisle, A Greenberg et al
04 November 2025
Register
 In conversation with Nina Bauer: CAR-T milestones, navigating investment landscapes, and the three Ps of CGT

In conversation with Nina Bauer: CAR-T milestones, navigating investment landscapes, and the three Ps of CGT

Nina Bauer
29 October 2025
Interview
 Accelerating AAV process development with high-throughput strategies

Accelerating AAV process development with high-throughput strategies

Dan Matuszek
28 October 2025
Watch
 In conversation with Alexis Cockroft: driving sustainable, globally accessible cell and gene therapies through

In conversation with Alexis Cockroft: driving sustainable, globally accessible cell and gene therapies through

Alexis Cockroft
28 October 2025
Interview
 Automating autologous CAR T manufacturing: Timing, technology transfer and the future of operational efficiency

Automating autologous CAR T manufacturing: Timing, technology transfer and the future of operational efficiency

Matthew Hewitt, Mojtaba Parvizi, Edwin Stone
22 October 2025
Watch
 Accelerated cell therapy manufacturing with optimized microbial quality control

Accelerated cell therapy manufacturing with optimized microbial quality control

Juliana Gutierrez, Roisin McGuigan
21 October 2025
Watch
 What do product-specific CQAs tell us about rAAV-based in vivo gene therapy products?

What do product-specific CQAs tell us about rAAV-based in vivo gene therapy products?

Yan Zhi
21 October 2025
Viewpoint
 Optimizing upstream cell culture with rapid at-line and in-line analytics

Optimizing upstream cell culture with rapid at-line and in-line analytics

Nick Randall, Ethan Bossange
16 October 2025
Watch
 Scaling smarter: a case study in overcoming cell therapy manufacturing and regulatory hurdles 

Scaling smarter: a case study in overcoming cell therapy manufacturing and regulatory hurdles 

James Adams, Ron Maddux
15 October 2025
Watch
 A science-driven framework for EV characterization to achieve clinical success

A science-driven framework for EV characterization to achieve clinical success

Davide Zocco
14 October 2025
Watch
 Unpacking the challenges of AAV gene therapy: exploring capsid engineering, immunogenicity management, and scalable manufacturing solutions

Unpacking the challenges of AAV gene therapy: exploring capsid engineering, immunogenicity management, and scalable manufacturing solutions

Sherif Gabriel
14 October 2025
Interview
 Closing the loop: eliminating open handling risks in CGT manufacturing

Closing the loop: eliminating open handling risks in CGT manufacturing

Erik Woods, Sean Werner, Jon Pileggi
09 October 2025
Watch